Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-017673-38Phase 4Active
Phase 4 trial of aripiprazole and risperidone in schizophrenia (3 arms), sponsored by Qualissima. Primary endpoint: Identification of brain circuits involved in emotional congruence task on fMRI. Started Feb 2010; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-017673-38.